Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: Assistance Publique - Hôpitaux de Paris
Condition: MSI, dMMR Colorectal Cancer
NCT06152523
Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The study has been halted because the manufacturer can no longer supply the experimental treatment